04.25.24 -- Reflection And Advancement: J&J's Global Immunology Leader

Adept CRO communication doesn’t just indicate the vendor’s ability to deliver a thoughtful bid; it demonstrates their ability to analyze, operationalize, and optimize a plan.

Consider several key points outlined in this article when deciding if a functional service approach could better serve a clinical team and its drug development study.

Uncover how the role of the Implementation Lead from PPD™ FSP ensures streamlined and expertly managed onboarding and resource allocation for FSP clinical research projects.

View the webinar to discover outsourcing options for highly potent oral solid dose therapies, and learn how CDMOs can transfer, handle, and deliver their product to clinic and to market.

For APAC companies, it's important to identify the differences in care standards, formulate strategies for compliance, and develop solutions to bridge the regulatory gap and realize FDA approval.

See how transformative technologies like AI and ML augment the regulatory professional workload to ensure compliance, patient accessibility, and rapid timelines for approval for global drug campaigns.

Delve into fundamental GxP principles, essential regulatory aspects, and underscores the critical role GxP plays in ensuring the achievement of prosperous and ethical clinical trials.

EU Annex 11 lays out the European Union’s regulations for using computerized systems during clinical trials. Learn how sponsors and sites seeking treatment approval in the EU must follow Annex 11.